Kathy Giusti is a powerful champion for medical research. Her trailblazing leadership has dramatically changed the way new treatments, discoveries and cures are found.
When Kathy Giusti learned in 1996 that she had multiple myeloma, a rare blood cancer, she was told she couldn’t expect to live much more than three or four years.
TIME 100: Kathy Giusti
What if you were told, at 37, you had three years to live? Kathy Giusti, diagnosed with multiple myeloma, decided to make memories for her 18-month-old daughter Nicole...
These 3 Former Business Leaders Are Disrupting Medicine
On the heels of her diagnosis of multiple myeloma (a rare blood cancer) in 1996, former G.D. Searle and Merck MRK -0.66% exec Kathy Giusti resolved to whip a fragmented cancer research community into shape by disrupting old models and centralizing data.